Institutional investors purchased a net $286.1 thousand shares of ENZ during the quarter ended April 2014. This may signal that the smart money is gaining interest in this company as the 33.81% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE TEACHERS RETIREMENT SYSTEM... Bought 124.9 Thousand shares of Enzo Biochem Inc